PALI
Palisade Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.09
+2.20%Margins
Gross margin
100.0%
EBITDA margin
-6643.8%
EBIT margin
-7069.8%
Net margin
-6388.2%
FCF margin
-3638.0%
-26.2%
Return on equity
-25.1%
Return on assets
-29.0%
Return on invested capital
0.00x
Asset turnover
-$18.2M
Cash from operations
$0.72
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026